Logo

Samuel Chapin

Oct 19, 2016

PerkinElmer has appointed Samuel Chapin to its board of directors. Chapin most recently served as executive vice chairman of global and corporate and investment banking for Bank of America Merrill Lynch. Since he joined Merrill Lynch in 1984, he has held a number of positions with increasing leaderships roles, including serving as vice chairman in September 2003, serving as senior vice president and head of the global investment banking division, and managing director in corporate banking.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.